Q4 2019 Earnings Forecast for Healthequity Inc Issued By Oppenheimer (HQY)

Healthequity Inc (NASDAQ:HQY) – Stock analysts at Oppenheimer lifted their Q4 2019 earnings per share estimates for shares of Healthequity in a research report issued to clients and investors on Thursday, February 7th. Oppenheimer analyst M. Naidu now forecasts that the company will post earnings per share of $0.16 for the quarter, up from their previous estimate of $0.12. Oppenheimer also issued estimates for Healthequity’s Q2 2020 earnings at $0.27 EPS, Q4 2020 earnings at $0.23 EPS and FY2020 earnings at $1.03 EPS.

Healthequity (NASDAQ:HQY) last released its quarterly earnings data on Tuesday, December 4th. The company reported $0.22 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.20 by $0.02. Healthequity had a net margin of 24.52% and a return on equity of 12.42%. The company had revenue of $70.50 million during the quarter, compared to analyst estimates of $69.60 million. During the same period in the prior year, the firm earned $0.17 earnings per share. The firm’s revenue for the quarter was up 24.1% compared to the same quarter last year.



Other analysts have also issued reports about the stock. BidaskClub lowered shares of Healthequity from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, November 13th. ValuEngine lowered shares of Healthequity from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, December 5th. Zacks Investment Research raised shares of Healthequity from a “hold” rating to a “buy” rating and set a $83.00 price objective for the company in a research note on Monday, December 10th. Citigroup set a $102.00 price objective on shares of Healthequity and gave the stock a “buy” rating in a research note on Tuesday, January 8th. Finally, SunTrust Banks raised shares of Healthequity from a “hold” rating to a “buy” rating and set a $81.00 price objective for the company in a research note on Thursday, February 7th. Four investment analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company. The company has an average rating of “Buy” and an average target price of $89.62.

NASDAQ:HQY opened at $72.51 on Monday. Healthequity has a 1-year low of $47.33 and a 1-year high of $101.58. The stock has a market capitalization of $4.47 billion, a P/E ratio of 134.28, a price-to-earnings-growth ratio of 2.41 and a beta of 1.64.

In other Healthequity news, Director Frank Corvino sold 2,068 shares of the stock in a transaction dated Wednesday, December 12th. The shares were sold at an average price of $70.81, for a total transaction of $146,435.08. Following the completion of the sale, the director now directly owns 5,051 shares of the company’s stock, valued at $357,661.31. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, VP Darcy G. Mott sold 4,000 shares of the stock in a transaction dated Tuesday, November 20th. The shares were sold at an average price of $76.91, for a total transaction of $307,640.00. Following the sale, the vice president now directly owns 89,500 shares of the company’s stock, valued at $6,883,445. The disclosure for this sale can be found here. Over the last three months, insiders have sold 15,846 shares of company stock valued at $1,058,948. Insiders own 4.00% of the company’s stock.

Several institutional investors and hedge funds have recently bought and sold shares of the company. BlackRock Inc. increased its holdings in shares of Healthequity by 1.6% during the fourth quarter. BlackRock Inc. now owns 6,764,271 shares of the company’s stock valued at $403,489,000 after acquiring an additional 109,127 shares in the last quarter. Morgan Stanley increased its holdings in shares of Healthequity by 15.5% during the third quarter. Morgan Stanley now owns 4,001,425 shares of the company’s stock valued at $377,775,000 after acquiring an additional 536,366 shares in the last quarter. FMR LLC increased its holdings in shares of Healthequity by 2.3% during the third quarter. FMR LLC now owns 3,488,107 shares of the company’s stock valued at $329,312,000 after acquiring an additional 77,565 shares in the last quarter. Bank of New York Mellon Corp increased its holdings in shares of Healthequity by 13.5% during the fourth quarter. Bank of New York Mellon Corp now owns 990,402 shares of the company’s stock valued at $59,076,000 after acquiring an additional 118,080 shares in the last quarter. Finally, Victory Capital Management Inc. increased its holdings in shares of Healthequity by 9.1% during the third quarter. Victory Capital Management Inc. now owns 724,729 shares of the company’s stock valued at $68,422,000 after acquiring an additional 60,669 shares in the last quarter. Hedge funds and other institutional investors own 94.07% of the company’s stock.

About Healthequity

HealthEquity, Inc provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company offers healthcare saving and spending platform, a cloud-based platform for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

Recommended Story: Marijuana Stocks Investing Considerations

Earnings History and Estimates for Healthequity (NASDAQ:HQY)

Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply